Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
CB-ChMF-12
- Development stage
- Preclinical
- Lead developer
- Corion Biotech
- Modality
- Other Cell Types → Cell Therapies
01
Overview
CB-ChMF-12 is a cell-free biologic drug candidate being developed by Corion Biotech (Corinca) for the treatment of epithelial cancers, including ovarian and breast cancer. It consists of conditioned medium (the secretome) derived from human Placenta-Derived Mesenchymal Stem Cells (hPDMSCs) that are specifically isolated from preeclamptic placentas. This "cell therapy without cells" approach utilizes the unique properties of the preeclamptic secretome, which has been shown to exhibit anti-angiogenic action and the ability to inhibit oncogene expression. CB-ChMF-12 is currently in the discovery/preclinical stage of development and is protected by patents in multiple regions, including the EU, USA, Canada, China, and Japan.
- Other names
- CB-ChMF-12-Corinca-conditioned mediumCB-ChMF12-Corinca-conditioned mediumCB-ChMF 12-Corinca-conditioned mediumhPDMSCs-derived conditioned mediumcell-free biologic
Beyond the preview
Go deeper on CB-ChMF-12.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on CB-ChMF-12.